Based on the above-described multidirectional and important role of the CCL2-CCR2 axis in the brain, it can be expected that interference with this signaling pathway may disrupt numerous immune-neuronal processes that underlie the development of depressive disorders (Fig. 1). The gene discussed is CCL2; the disease is depressive disorder.